ALT BioScience™ is a speciality bioscience company that discovers, develops and commercializes diagnostic and biomedical technologies.

We are focused on oral health and improving systemic disease outcomes and neurodegenerative diseases, such as Alzheimer's and ALS.

Our foundation, nucleotide photoaffinity labeling is an integral research tool for nearly 300 research and academic institutions for diseases such as cancer and metabolic disorders.

We are committed to providing answers that help make a difference through research and innovation of new diagnostics for some of the world's most unmet medical needs.